A 33 year old man mentioned fatigue; headaches; painful, enlarged breasts; and impotence. Overall survival is shorter in men, possibly because they tend to be older and have more comorbid conditions. Men usually are offered adjuvant hormone therapy with tamoxifen 20 mg/day for five years, as several retrospective studies have shown improved survival.24 If the tumour has adverse features, adjuvant systemic therapy (chemotherapy or HER2 antibody trastuzumab, or both) should be offered. Complications include haematoma, seroma, infection, sensory changes, pain, breast asymmetry, skin redundancy, and scarring.22 23 The most common complication is a poor cosmetic outcome. A family history of breast cancer increases the risk of breast cancer in males. Men with Klinefelter’s syndrome, who have testicular failure shortly after puberty, have a 58-fold higher risk than normal males for breast cancer, with an absolute risk that approaches 3%.11 Breast cancer has been reported in male to female transsexuals who were castrated and given high dose oestrogen. We searched Medline for English language papers with the key words "gynaecomastia", "gynecomastia", and "male breast cancer"; the Cochrane database for clinical trials; our personal archives of references; and websites with those terms. But if it’s caused by long-term hormonal imbalances or other medical conditions then treatment is needed to reduce or get rid of the breast tissue. The lump may move easily within the breast tissue and may be tender to touch. Gynecomastia most often happens due to an imbalance of hormones — specifically testosterone and estrogen. Obesity can also cause an increase in breast size due to excess adipose (fat) tissue. Certain medications and medical conditions can also cause it. Regular self-examinations can help identify any changes in breast tissue early on. One of the primary symptoms of gynecomastia is the presence of swollen or enlarged breast tissue. In rare cases, gynecomastia may be caused by hormonal imbalances or underlying medical conditions such as liver disease or testicular tumors. Excess body fat can lead to increased estrogen production, while alcohol consumption can disrupt hormone levels and affect liver function. The surgical technique used depends on the degree of the gynecomastia and the distribution and proportion of the different breast components (fat, parenchyma and looseness of the skin envelope). Testolactone is an aromatase inhibitor was tested in a small, uncontrolled trial of pubertal gynecomastia; results were positive.7,11 Overall, the use of aromatase inhibitors is supported by incomplete evidence and the potential benefits and adverse effects should be considered before commencing treatment. Aromatase Inhibitors–these powerful agents block estrogen synthesis and as such decrease the estrogen to androgen ratio. Because it rapidly reduces pain, it should be considered a first-line treatment for symptomatic cases of acute gynecomastia, or those that fail to resolve spontaneously. Increasing glandular tissue in adult men increases the concern for malignancy. The excess risk in male carriers of BRCA1 is much less. †Cytochrome P450c17a gene coding enzyme involved in oestrogen and androgen synthesis. Several families (fathers and sons) have been described with oestrogen excess due to mutations activating the aromatase gene.9 They developed prepubertal gynaecomastia and accelerated prepubertal growth. Gynaecomastia may follow cancer treatment if chemotherapy or radiation damages Leydig cells. Androgen catabolism is reduced in liver disease, making more available for conversion to oestrogen in peripheral tissue. Malnourishment can cause gynecomastia due to decreased gonadotropin and T levels, coupled with normal production of estrogens (and their precursors) from the adrenal glands. Spironolactone is also used to treat cirrhotic patients, which can exacerbate the condition.11,15 Alcohol use can also disrupt the hypothalamic–pituitary–testicular axis, causing a candy96.fun decrease in serum T levels. Interestingly, more than half of the patients with persistent pubertal gynecomastia have a family history of the condition. They block the effects of estrogen on breast tissue which can reverse the growth. Drugs like tamoxifen shrink breast tissue in men with gynecomastia. Exercise and weight management are important for overall health but in the case of true gynecomastia the breast tissue won’t decrease much with weight loss alone. This procedure involves the surgical removal of the glandular breast tissue that causes gynecomastia. These tumors influence hormonal levels, resulting in signs like gynecomastia. The use of alcohol, marijuana, and anabolic steroids can increase the risk of developing gynecomastia. After the tissue has become scarred, medications are not likely to be effective, and surgical removal is the only possible treatment. Gynecomastia, especially in pubertal males, often goes away on its own within about six months, so observation is preferred over specific treatment in many cases. During puberty, levels of these hormones may fluctuate and rise at different levels, resulting in a temporary state in which estrogen concentration is relatively high. Any condition or imbalance that disturbs the harmony of testosterone and oestrogen can also raise the likelihood of Gynaecomastia. Finally, family history of gynecomastia should be assessed, which may suggest androgen insensitivity syndrome, familial aromatase excess, or Sertoli cell tumors.2,5,11 A healthy male with long-stable gynecomastia and a negative history and physical examination generally does not require further evaluation. Bodybuilders who abuse anabolic steroids to increase muscle mass may also develop gynecomastia. Males with long-standing type 1 diabetes mellitus may develop diabetic mastopathy, presenting with hard diffuse enlargements of one or both breasts. Increased serum cortisol and E2 levels, combined with decreased serum T, have been reported in patients under extreme stress.
